Your browser doesn't support javascript.
loading
Circulating Immune Bioenergetic, Metabolic, and Genetic Signatures Predict Melanoma Patients' Response to Anti-PD-1 Immune Checkpoint Blockade.
Triozzi, Pierre L; Stirling, Elizabeth R; Song, Qianqian; Westwood, Brian; Kooshki, Mitra; Forbes, M Elizabeth; Holbrook, Beth C; Cook, Katherine L; Alexander-Miller, Martha A; Miller, Lance D; Zhang, Wei; Soto-Pantoja, David R.
Afiliação
  • Triozzi PL; Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Stirling ER; Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Song Q; Wake Forest Baptist Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Westwood B; Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Kooshki M; Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Forbes ME; Wake Forest Baptist Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Holbrook BC; Center for Cancer Genomics and Precision Oncology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Cook KL; Department of Surgery, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Alexander-Miller MA; Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Miller LD; Wake Forest Baptist Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Zhang W; Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Soto-Pantoja DR; Department of Microbiology & Immunology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Clin Cancer Res ; 28(6): 1192-1202, 2022 03 15.
Article em En | MEDLINE | ID: mdl-35284940
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article